Growing community of inventors

Watchung, NJ, United States of America

Larisa Reyderman

Average Co-Inventor Count = 2.50

ph-index = 5

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 54

Larisa ReydermanZhihui Qiu (4 patents)Larisa ReydermanHeike Keilhack (2 patents)Larisa ReydermanSarah Kathleen Knutson (2 patents)Larisa ReydermanDanielle Johnston Blackwell (2 patents)Larisa ReydermanLone Ottesen (2 patents)Larisa ReydermanZhihui Qiu (1 patent)Larisa ReydermanL Danielle Johnston (0 patent)Larisa ReydermanDanielle L Johnston (1 patent)Larisa ReydermanLone Ottesen (1 patent)Larisa ReydermanLarisa Reyderman (6 patents)Zhihui QiuZhihui Qiu (7 patents)Heike KeilhackHeike Keilhack (32 patents)Sarah Kathleen KnutsonSarah Kathleen Knutson (31 patents)Danielle Johnston BlackwellDanielle Johnston Blackwell (4 patents)Lone OttesenLone Ottesen (2 patents)Zhihui QiuZhihui Qiu (2 patents)L Danielle JohnstonL Danielle Johnston (0 patent)Danielle L JohnstonDanielle L Johnston (1 patent)Lone OttesenLone Ottesen (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Opko Health, Inc. (3 from 26 patents)

2. Eisai R&d Management Co., Ltd. (2 from 530 patents)

3. Epizyme, Inc. (2 from 158 patents)

4. Schering Corporation (1 from 1,829 patents)


6 patents:

1. 11642347 - EZH2 inhibitors for treating lymphoma

2. 10166238 - EZH2 inhibitors for treating lymphoma

3. 9345692 - Pharmaceutical formulations: salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxy-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same

4. 8404702 - Pharmaceutical formulations:salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same

5. 7981905 - Pharmaceutical formulations: salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-Ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same

6. 7563801 - Pharmaceutical formulations: salts of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/10/2026
Loading…